hypogonadism

TRAVERSE Trial: CV Safety of Testosterone-Replacement Therapy

TRAVERSE Trial Summary The abstract highlights the findings of the TRAVERSE trial, which aimed to assess the cardiovascular safety of testosterone-replacement therapy in middle-aged and older men with hypogonadism. The trial sought to determine whether testosterone replacement therapy in this … Read More